Avandia
Avandia Background:
Avandia (Rosiglitazone) is manufactured by GlaxoSmithKline. Avandia is a prescribed drug that treats Type-2 Diabetes Mellitus. Patients are prescribed Avandia to help control and regulate their blood sugar levels.
FDA Response:
Avandia was approved by the FDA for use in 1999. In 2007, the FDA required GlaxoSmithKline to revise its Black Box warning. A Black Box warning is the strongest form of warning on a prescription medication. The upgraded warning stated that Avandia has been “associated with an increased risk of myocardial ischemic events such as angina or myocardial infarction.” The FDA also requested that GlaxoSmithKline conduct a long-term study to evaluate the potential cardiovascular risk of Avandia.
Avandia Problems:
You may have been harmed by Avandia if you have suffered the following:
- Heart Attack
- Congestive Heart Failure
- Aneurysms
- Arrhythmia
- Liver Toxicity
- Severe Allergic Reaction
- Osteoporosis
- Stroke
- Death
Avandia Litigation:
James, Vernon & Weeks, P.A. seeks to protect the rights of individuals who have been harmed by Avandia. James, Vernon & Weeks, P.A. represents individuals suffering from Avandia on a contingency basis. Contingency basis means that there are never any legal fees unless James, Vernon & Weeks, P.A. wins compensation in your case.
